Effect of AZD4017, a Selective 11ß-HSD1 Inhibitor, on Bone Turnover Markers in Postmenopausal Osteopenia (2022)

First Author: Abbas A
Attributed to:  Centre for Integrated research into Musculoskeletal Ageing (CIMA) Renewal funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1210/clinem/dgac100

PubMed Identifier: 35275196

Publication URI: http://europepmc.org/abstract/MED/35275196

Type: Journal Article/Review

Parent Publication: The Journal of Clinical Endocrinology & Metabolism

Issue: 7

ISSN: 0021-972X